Top compounds associated with response to RRP15


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.07
mRNA elocalcitol CTRPv2 pan-cancer AAC 0.065 0.07
mRNA GNF-2 GDSC1000 pan-cancer AAC -0.098 0.07
mRNA QS11 GDSC1000 pan-cancer AAC 0.065 0.07
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.091 0.07
mRNA alvocidib CTRPv2 pan-cancer AAC 0.09 0.07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.07
mRNA Topotecan CCLE pan-cancer AAC 0.077 0.07
mRNA AC220 GDSC1000 pan-cancer AAC -0.063 0.07
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC 0.14 0.07
Download CSV